Literature DB >> 2010905

Role of a large plasmid of Salmonella typhi encoding multiple drug resistance.

S Karmaker1, D Biswas, N M Shaikh, S K Chatterjee, V K Kataria, R Kumar.   

Abstract

Twenty isolates of Salmonella typhi from cases of typhoid during the 1989-1990 epidemic in Calcutta were examined. Most isolates (84% of all isolates in the epidemic) were resistant to chloramphenicol, ampicillin, tetracycline and streptomycin but were sensitive to nalidixic acid and ciprofloxacin. Plasmids of 120 kb and 14 kb were identified amongst the multi-drug resistant isolates of S. typhi. However, there was no plasmid in the antibiotic-sensitive isolates. The 120-kb plasmid was transferable and transconjugants were resistant to chloramphenicol, ampicillin, tetracycline and streptomycin. Restriction endonuclease analysis patterns after EcoRI digestion of the 120-kb antibiotic-resistance plasmids from the S. typhi isolates and transconjugants were similar.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010905     DOI: 10.1099/00222615-34-3-149

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  3 in total

1.  Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India.

Authors:  Shanta Dutta; Dipika Sur; Byomkesh Manna; Sujit K Bhattacharya; Jacqueline L Deen; John D Clemens
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India.

Authors:  P M Shanahan; M V Jesudason; C J Thomson; S G Amyes
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Endemic, epidemic clone of Salmonella enterica serovar typhi harboring a single multidrug-resistant plasmid in Vietnam between 1995 and 2002.

Authors:  Thi Anh Hong Le; Monique Lejay-Collin; Patrick A D Grimont; Thuy Long Hoang; Thi Vinh Nguyen; Francine Grimont; Maurice R Scavizzi
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.